HIV pozitif hastada tüberküloz olgusu
Yıl: 2017 Cilt: 32 Sayı: 3 Sayfa Aralığı: 198 - 201 Metin Dili: Türkçe DOI: 10.5222/MMJ.2017.198 İndeks Tarihi: 03-04-2019
HIV pozitif hastada tüberküloz olgusu
Öz: Akciğer tüberkülozu (TB), İnsan immun yetmezlik virüsü (HIV) po- zitif bireylerde mortaliteye neden olabilmekte ve ayrıca hastalığın progresyonunu hızlandırıp AIDS tablosunun gelişimine yol açabil- mektedir. Antiretroviral (ART) tedavi ve anti-tüberküloz tedavi birlikte alınması nedeniyle ilaç etkileşimi riski artmaktadır. Çoklu ilaç kullanımına bağlı ilaç uyumu azalmaktadır. Ayrıca her iki has- talık da immunsupresyonu artırmaktadır. Bu faktörler nedeniyle HIV pozitifliği ve TB birlikteliği önemlidir. Bu vaka sunumunda, HIV pozitifliği nedenli takip edilen, konstitüsyonel semptomlarla hastanemize başvuran ve sonuçta akciğer TB tanısı alan bir hasta sunuldu. HIV pozitif olguların klinik gidişatı yakından takip edil- meli ve akciğer grafilerindeki değişiklikler TB açısından dikkatlice değerlendirilmelidir.
Anahtar Kelime: Konular:
A case of pulmonary tuberculosis in a HIV-positive patient
Öz: Pulmonary tuberculosis (TB) can cause mortality in human im- munodeficiency virus (HIV) positive patients and can also accele- rate the progression of the disease leading to the development of AIDS. Concurrent antiretroviral (ART) and anti-tuberculosis treatment increases the risk of drug interactions. Polypharmacy decreases the compliance of the patient to medication. Both di- seases also increase immunosuppression. Due to these factors, combination of HIV positivity and TB is important. In this case report, a patient who was followed up because of HIV positivity, and, applied to our hospital with constitutional symptoms, and then diagnosed as pulmonary TB was presented. Clinical course of HIV-positive patients should be monitored closely and their ra- diological changes should be carefully evaluated for TB.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- Tuberculosis and HIV. Available at: http://www.who.int/hiv/ topics/tb/about_tb/en/ (Erişim 08 Nisan 2014).
- Badur S. 2007 yılında AIDS: nereden nereye geldik? Ankem Derg 2007;21(Suppl. 2):1-6.
- 2015 AIDS Epidemic Update [İnternet]. Geneva: WHO Jo- int United Nations Programme on HIV/AIDS (UNAIDS) [Eri- şim: 8 Nisan 2016]. AIDS by number 2015. http://www. unaids.org/sites/default/files/media_asset/AIDS_by_the_ numbers_2015_en.pdf.
- HIV/AIDS epidemiyolojisi ve korunma [İnternet]. Ankara: Ha- cettepe Üniversitesi HIV/AIDS Tedavi ve Araştırma Merkezi [Erişim: 8 Nisan 2016]. http://www.hatam.hacettepe.edu.tr/ veriler_Haziran_2014.pdf.
- World Health Organization. Global Tuberculosis Report 2014 (Erişim: 08 Nisan 2016).
- Brassard P, Remis RS. Incidence of tuberculosis among re- ported AIDS cases in Quebac from 1979 to 1996. CMAJ 1999;160:1838-1842.
- Holmes CB, Losina E, Walensky RP, et al. Review of Human Immunodeficiency Virus, Type I related opportunistic Infecti- ons ın Sub-Saharan Africa. Clin Infec Dis 2003;36:652-662. https://doi.org/10.1086/367655
- Alberto Matteelli. TB and HIV: from clinical practice to pub- lic health action. ERS Online Course on Tuberculosis, Italy. March 2011.
- Çelikbaş AK, Eren Ş, Esener H, et al. HIV İnfeksiyonu ve TÜ- BERKÜLOZ. Türk HIV/AIDS Dergisi 2004;7(3):77-81.
- Kaya S, Yılmaz G, Erensoy Ş, et al. HIV/AIDS’li 36 olgunun retrospektif analizi retrospective analysis of 36 HIV/AIDS cases. Klimik Dergisi 2011;24(1):11-6. https://doi.org/10.5152/kd.2011.03
- Dragsted UB, Bauer J, Poulsen S, et al. Epidemiology of Tu- berculosis in HIV-infected Patients in Denmark. Scandinavian Journal of Infectious Diseases 1999;31(1):57-61. https://doi.org/10.1080/00365549950161899
- Sonnenberg P, Glynn JR, Fielding K, et al. How soon after in- fection with HIV does the risk of tuberculosis start to increa- se? A retrospective cohort study in South African goldminers. J Infect Dis 2005;191:150. https://doi.org/10.1086/426827
- Geldmacher C, Schuetz A, Ngwenyama N, et al. Earlydeple- tion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J Infect Dis 2008;198:1590. https://doi.org/10.1086/593017
- Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000;23:75.https://doi.org/10.1097/00042560-200001010-00010
- Holmes CB, Wood R, Badri M, et al. CD4 decline and inci- dence of opportunisticinfections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr 2006;42:464. https://doi.org/10.1097/01.qai.0000225729.79610.b7
- Selwyn PA, Hartel D, Lewis VA, et al. A prospectivestudy of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545. https://doi.org/10.1056/NEJM198903023200901
- Lahey T, Mackenzie T, Arbeit RD, et al. Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis. Clin Infect Dis 2013;56:151. https://doi.org/10.1093/cid/cis798
- Kruk A, Wendy B, Daria NP, et al. Tuberculosis among HIV- positive patients across Europe: changes over time and risk factors. EuroSIDA study group. AIDS 2011;25(12):1510. https://doi.org/10.1097/QAD.0b013e328348fafd
| APA | YAKAR H, SARGIN F, Kanbay A, CEYLAN E (2017). HIV pozitif hastada tüberküloz olgusu. , 198 - 201. 10.5222/MMJ.2017.198 |
| Chicago | YAKAR HALİL İBRAHİM,SARGIN Fatma,Kanbay Asiye,CEYLAN Erkan HIV pozitif hastada tüberküloz olgusu. (2017): 198 - 201. 10.5222/MMJ.2017.198 |
| MLA | YAKAR HALİL İBRAHİM,SARGIN Fatma,Kanbay Asiye,CEYLAN Erkan HIV pozitif hastada tüberküloz olgusu. , 2017, ss.198 - 201. 10.5222/MMJ.2017.198 |
| AMA | YAKAR H,SARGIN F,Kanbay A,CEYLAN E HIV pozitif hastada tüberküloz olgusu. . 2017; 198 - 201. 10.5222/MMJ.2017.198 |
| Vancouver | YAKAR H,SARGIN F,Kanbay A,CEYLAN E HIV pozitif hastada tüberküloz olgusu. . 2017; 198 - 201. 10.5222/MMJ.2017.198 |
| IEEE | YAKAR H,SARGIN F,Kanbay A,CEYLAN E "HIV pozitif hastada tüberküloz olgusu." , ss.198 - 201, 2017. 10.5222/MMJ.2017.198 |
| ISNAD | YAKAR, HALİL İBRAHİM vd. "HIV pozitif hastada tüberküloz olgusu". (2017), 198-201. https://doi.org/10.5222/MMJ.2017.198 |
| APA | YAKAR H, SARGIN F, Kanbay A, CEYLAN E (2017). HIV pozitif hastada tüberküloz olgusu. Medeniyet Medical Journal, 32(3), 198 - 201. 10.5222/MMJ.2017.198 |
| Chicago | YAKAR HALİL İBRAHİM,SARGIN Fatma,Kanbay Asiye,CEYLAN Erkan HIV pozitif hastada tüberküloz olgusu. Medeniyet Medical Journal 32, no.3 (2017): 198 - 201. 10.5222/MMJ.2017.198 |
| MLA | YAKAR HALİL İBRAHİM,SARGIN Fatma,Kanbay Asiye,CEYLAN Erkan HIV pozitif hastada tüberküloz olgusu. Medeniyet Medical Journal, vol.32, no.3, 2017, ss.198 - 201. 10.5222/MMJ.2017.198 |
| AMA | YAKAR H,SARGIN F,Kanbay A,CEYLAN E HIV pozitif hastada tüberküloz olgusu. Medeniyet Medical Journal. 2017; 32(3): 198 - 201. 10.5222/MMJ.2017.198 |
| Vancouver | YAKAR H,SARGIN F,Kanbay A,CEYLAN E HIV pozitif hastada tüberküloz olgusu. Medeniyet Medical Journal. 2017; 32(3): 198 - 201. 10.5222/MMJ.2017.198 |
| IEEE | YAKAR H,SARGIN F,Kanbay A,CEYLAN E "HIV pozitif hastada tüberküloz olgusu." Medeniyet Medical Journal, 32, ss.198 - 201, 2017. 10.5222/MMJ.2017.198 |
| ISNAD | YAKAR, HALİL İBRAHİM vd. "HIV pozitif hastada tüberküloz olgusu". Medeniyet Medical Journal 32/3 (2017), 198-201. https://doi.org/10.5222/MMJ.2017.198 |
